Strategic partnerships Leverage existing collaborations with leukemia and myeloma research organizations and UK healthcare partners to expand cord blood storage partnerships and clinical use programs, positioning Smart Cells as a preferred private storage and translational research partner.

Public market momentum Capitalize on Merck’s prior acquisition and ongoing stem cell therapy demand by highlighting trusted outcomes, IP position, and potential for co-development or licensing opportunities with larger biopharma companies seeking complementary cord blood and stem cell solutions.

Clinical utility expansion Target hospitals and pediatric centers with turnkey cord blood storage and translation pathways, emphasizing success in treating life-threatening pediatric illnesses and the potential to broaden indications as technology evolves.

Revenue growth levers Promote scalable storage services, including premium customer care and rapid sample release capabilities, to increase unit economics and convert more families into long-term, recurring clients while pursuing enterprise accounts in private healthcare networks.

Brand credibility Highlight leadership in private UK stem cell storage and the strongest sample release track record to differentiate from competitors and attract strategic investor interest or channel partners in the biotech ecosystem.